(Q34536314)

2 August 2017

1 reference

title

'...and C is for Clioquinol' - the AbetaCs of Alzheimer's disease (English)

1 reference

2 August 2017

0 references

Simon Melov

1

1 reference

2 August 2017

language of work or name

1 reference

1 March 2002

1 reference

2 August 2017

published in

Trends in Neurosciences

1 reference

2 August 2017

volume

25

1 reference

2 August 2017

issue

3

1 reference

2 August 2017

page(s)

121-3; discussion 123-4

1 reference

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Rapid induction of Alzheimer A beta amyloid formation by zinc.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Copper, iron and zinc in Alzheimer's disease senile plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Specific metal-catalysed protein oxidation reactions in chronic degenerative disorders of ageing: focus on Alzheimer's disease and age-related cataracts.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Clioquinol's return: cautions from Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Changes in uptake of vitamin B(12) and trace metals in brains of mice treated with clioquinol

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-2236%2800%2902086-5

7 January 2021

10.1016/S0166-2236(00)02086-5

Identifiers

DOI

1 reference

2 August 2017

1 reference